Pioneering a novel approach to
treating chronic disease with


Learn more

Our Purpose

Serious chronic diseases today are often treated with chronic therapies. For patients with diseases such as lysosomal diseases or type 1 diabetes, they often are treated with frequent injections or infusions — sometimes multiple times daily — and constant, lifelong vigilance to manage their disease.


We developed our Shielded Living Therapeutics™ platform to address these treatment challenges. Leveraging advances in cell engineering and our proprietary biocompatible materials, we created a pipeline of potential therapies capable of producing proteins, enzymes and other therapeutic molecules that may be missing or deficient in the body—potentially resulting in functional cures for patients with a wide range of chronic diseases.

Learn more